---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000789"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:23:08.856691+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma COO Dr. Abderrazzak Merzouki resigns effective immediately

## Summary
- Dr. Abderrazzak Merzouki resigned as COO of Sunshine Biopharma on February 5, 2026, effective immediately.
- No replacement or interim COO has been announced in the filing.
- The resignation is reported under Item 5.02 with no stated reason for departure.

## SEC filing metadata
- accession: 0001683168-26-000789
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/0001683168-26-000789-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000789
- JSON: https://secwatch.observer/filing/0001683168-26-000789.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000789.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.